Phase 3 Trial to Evaluate the Efficacy and Safety of DKP21102_B Added on to DKP21102_A Compared With DKP21102_A

NCT05809687 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped The clinical trial was withdrawn due to a commercial decision.

Conditions

Dyslipidemias

Interventions

DRUG: DKP21102_C
DRUG: DKP21102_B
DRUG: DKP21102_A

Sponsor

Dongkwang Pharm. Co., Ltd.